# The Human Medicines Regulations 2012, Paragraph 7

Extent: E+W+S+N.I.

The entries or a succinct statement of the entries (if any) in the summary of the product characteristics, or in any equivalent summary published by the holder of a temporary authorisation, relating to—
(a) adverse reactions, precautions and relevant contra-indications;
(b) dosage and method of use so far as relevant to the indications shown in the advertisement, and
(c) where this is not obvious, method of administration so far as relevant to those indications.

---
Source: https://www.legislation.gov.uk/uksi/2012/1916/schedule/30/paragraph/7 (the official version)
Page: https://openlegislation.uk/human-medicines-regulations-2012/schedule-30/paragraph-7
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.